Ozempic Goes Generic in India at Fourteen Dollars a Month
Novo Nordisk's semaglutide patent expired March 20 and Indian drugmakers launched generics at $14 a month — the same drug costs $1,000 in the US.
Priya Sharma
Bureau: Delhi
Third Sanctions Waiver in Two Weeks and Washington Is Running Out of Options
The Treasury issued its third sanctions waiver in two weeks, releasing 140 million barrels of Iranian oil, but analysts warn the economic toolkit is nearly exhausted.
Fibermaxxing Has Replaced Protein as the Internet's Favorite Nutrient
TikTok's fibermaxxing trend has 150 million views, a Tufts study backing it, and Whole Foods calling fiber the top food trend of 2026.
India's Tech Industry Hits $315 Billion as AI Moves From Experiment to Factory Floor
India's tech sector will reach $315 billion in FY26 revenue with AI services alone generating $10-12 billion annually — the shift from experimentation to industrialization.
India's 8.8 Million Gulf Workers Are the War's Invisible Casualties
Over 52,000 Indians have fled the Gulf in a week as the Iran war disrupts flights, gas supplies, and the $100 billion remittance pipeline sustaining Indian households.